Sanjib O Bera from 400 Algonquin Ct, Blacksburg, VA 24060, age 56, Phone: (540)9514846

Us Patents

Methods Of Inhibiting Orthopoxvirus Replication With Nucleoside Compounds
view source
US Patent:

7323453, Jan 29, 2008
Filed:

Feb 7, 2003
Appl. No.:

10/504445
Inventors:

David B. Olsen - Lansdale PA, US
Robert L. LaFemina - Schwenksville PA, US
Anne B. Eldrup - Danbury CT, US
Sanjib Bera - Blacksburg VA, US
Assignee:

Merck & Co., Inc. - Rahway NJ
Isis Pharmaceuticals, Inc. - Carlsbad CA
International Classification:

A01N 43/04
A61K 31/70
C07H 19/00
C07H 19/22
US Classification:

514 48, 514 43, 514 45, 514 46, 514 47
Abstract:

The present invention provides methods of inhibiting orthopoxvirus replication and/or treating orthopoxvirus infection with certain nucleoside compounds and derivatives thereof. These compounds are particularly useful as inhibitors of vaccinia virus and variola virus replication and/or for the treatment of vaccinia virus and variola virus infection. The nucleoside compounds may be administered alone or in combination with other agents active against orthopoxvirus infection, in particular against vaccinia virus or variola virus infection. Another aspect of the present invention provides for the use of such nucleoside compounds in the manufacture of a medicament for the inhibition of orthopoxvirus replication and/or for the treatment of orthopoxvirus infection. Yet a further aspect of the present invention provides such nucleoside compounds for use as a medicament for the inhibition of orthopoxvirus replication and/or for the treatment of orthopoxvirus infection.

Compounds And Compositions For Prevention Of Overdose Of Oxycodone
view source
US Patent:

8106016, Jan 31, 2012
Filed:

Dec 8, 2006
Appl. No.:

11/635788
Inventors:

James Scott Moncrief - Christiansburg VA, US
Suma Krishnan - Belvedere CA, US
Travis Mickle - Coralville IA, US
Christopher Lauderback - Lovettsville VA, US
Sanjib Bera - Blacksburg VA, US
Sven Guenther - Blacksburg VA, US
Wendy Hirschelman - Blacksburg VA, US
Assignee:

Shire LLC - Florence KY
International Classification:

A61K 38/00
A61K 38/04
A61K 38/06
A61K 31/00
A61K 51/00
A61P 25/04
A61P 23/00
US Classification:

514 184, 514 183, 514 11, 530331, 530330, 530300, 424 781, 424 169
Abstract:

The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.

Compounds And Compositions For Prevention Of Overdose Of Oxycodone
view source
US Patent:

20050176644, Aug 11, 2005
Filed:

Sep 30, 2004
Appl. No.:

10/955006
Inventors:

Travis Mickle - Charlottesville VA, US
Suma Krishnan - Blacksburg VA, US
James Moncrief - Christiansburg VA, US
Christopher Lauderback - Blacksburg VA, US
Sanjib Bera - Blacksburg VA, US
Sven Guenther - Blacksburg VA, US
Wendy Hirschelman - Blacksburg VA, US
Assignee:

New River Pharmaceuticals Inc. - Radford VA
International Classification:

A61K038/08
A61K038/06
A61K038/05
US Classification:

514015000, 514016000, 514017000, 514018000, 514019000
Abstract:

The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.

Compounds And Compositions For Prevention Of Overdose Of Oxycodone
view source
US Patent:

20070066537, Mar 22, 2007
Filed:

Sep 30, 2004
Appl. No.:

10/953111
Inventors:

Travis Mickle - Blacksburg VA, US
Suma Krishnan - Blacksburg VA, US
James Moncrief - Blacksburg VA, US
Christopher Lauderback - Blacksburg VA, US
Thomas Piccariello - Blacksburg VA, US
Sanjib Bera - Blacksburg VA, US
Sven Guenther - Blacksburg VA, US
Wendy Hirschelman - Blacksburg VA, US
Assignee:

New River Pharmaceuticals Inc. - Radford VA
International Classification:

A61K 38/06
A61K 38/05
A61K 38/04
US Classification:

514016000, 514017000, 514018000, 514019000
Abstract:

The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to an opioid such as oxycodone in a manner that substantially decreases the potential of the opioid to cause overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction.

Mono And Di-Substituted Oxycodone Compounds And Compositions
view source
US Patent:

20110040072, Feb 17, 2011
Filed:

Mar 11, 2010
Appl. No.:

12/722495
Inventors:

Travis Mickle - Coralville IA, US
Suma Krishnan - Belvedere CA, US
James Scott Moncrief - Christiansburg VA, US
Christopher Lauderback - Lovettsville VA, US
Sanjib Bera - Blacksburg VA, US
Assignee:

SHIRE LLC - Florence KY
International Classification:

C07K 7/06
C07D 489/08
C07K 5/087
US Classification:

530330, 546 44, 530331
Abstract:

The invention relates to pharmaceutical compounds and compositions comprised of a chemical moiety attached to oxycodone in a manner that substantially decreases the potential for overdose. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of oxycodone and may also provide sustained release characteristics and/or reduced side-effects. Further the compounds and compositions of the invention are useful in preventing addiction and susceptibility to addiction of oxycodone.

Amino Acid Conjugates Of Quetiapine, Process For Making And Using The Same
view source
US Patent:

20110183963, Jul 28, 2011
Filed:

Dec 22, 2010
Appl. No.:

12/976546
Inventors:

Travis Mickle - Coralville IA, US
Sven Guenther - Coralville IA, US
Sanjib Bera - Blacksburg VA, US
International Classification:

A61K 31/554
C07D 267/02
A61P 25/18
A61P 25/32
A61P 25/24
A61P 25/00
A61P 25/20
US Classification:

51421113, 540551
Abstract:

The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized by chemically conjugating amino acids to quetiapine. The present technology also provides methods of treating patients, pharmaceutical compositions and methods of synthesizing conjugates of the present technology.

Fatty Acid Conjugates Of Quetiapine, Process For Making And Using The Same
view source
US Patent:

20110223207, Sep 15, 2011
Filed:

Mar 9, 2011
Appl. No.:

13/043764
Inventors:

Travis Mickle - Coralville IA, US
Sven Guenther - Coralville IA, US
Sanjib Bera - Blacksburg VA, US
International Classification:

A61K 31/554
A61K 9/00
A61K 33/00
A61P 25/18
US Classification:

424400, 51421113, 424722
Abstract:

The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized by chemically conjugating fatty acids to quetiapine. Pharmaceutical compositions and methods of synthesizing conjugates of the present technology are also provided. Methods of treating patients with the compositions of the present technology are also provided.

Amino Acid Conjugates Of Quetiapine, Process For Making And Using The Same
view source
US Patent:

20120276168, Nov 1, 2012
Filed:

Dec 22, 2010
Appl. No.:

13/518981
Inventors:

Travis Mickle - Coralville IA, US
Sven Guenther - Coralville IA, US
Sanjib Bera - Blacksburg VA, US
International Classification:

A61K 31/554
A61K 33/00
C07D 417/04
A61P 25/20
A61P 25/22
A61P 25/32
A61P 25/24
A61K 9/00
A61P 25/18
US Classification:

424400, 424722, 51421113, 540551
Abstract:

The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized bu chemically conjugating amino acids to quetiapine. The present technology also provides methods of treating patients, pharmaceutical compositions and methods of synthesizing conjugates of the present technology.